Cho Esther
Chief Legal Officer
Cho Esther has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Cho Esther is listed as Chief Legal Officer at Keros Therapeutics, Inc. Inside the rolling window, Cho Esther reported no open-market purchases and 2 open-market sales totaling $124K in KROS. The largest disclosed transaction in the window is a sale of 4,745 KROS shares on Feb 18, 2026, worth $78K.
Companies traded
Other insiders at KROS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$124K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cho Esther made?
Cho Esther has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Cho Esther trade?
Cho Esther has filed SEC Form 4 disclosures for 1 company, including KROS.
When was Cho Esther's most recent SEC Form 4 filing?
Cho Esther's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Cho Esther's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cho Esther is listed as Chief Legal Officer.
What is Cho Esther's total buy and sell value in the current window?
Inside the rolling retention window, Cho Esther bought $0 and sold $124K based on SEC Form 4 filings.
What was Cho Esther's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,745 KROS shares on 2026-02-18, worth $78K, per SEC Form 4 filings.